ライフサイエンスコーパス: technetium 99m

1 icotinamide, annexin V was radiolabeled with technetium 99m.

2 gregates of human serum albumin labeled with technetium 99m.

3 mission computed tomography (SPECT) with the technetium-99m-6-hydrazinylnicotinoyl-C-C-chemokine rece

4 Traditional tracers included technetium 99m ( 99m Tc) sulfur colloid, gallium 67, and

5 e, microsphere blood flow (MBF) testing, and technetium 99m ((99m)Tc) 2 methoxyisobutylisonitrile (MI

6 9 and August 2021 approximately 1 day before technetium 99m ((99m)Tc) 3,3-diphosphono-1,2-propanodica

7 onchial artery (90)Y radioembolization using technetium 99m ((99m)Tc) macroaggregated albumin (MAA) i

8 Tumor-absorbed dose was computed using technetium 99m ((99m)Tc) macroaggregated human albumin (

9 determine if commonly administered doses of technetium 99m ((99m)Tc) mertiatide (MAG3) in the range

10 elvic radiography and bone scintigraphy with technetium 99m ((99m)Tc) methylene diphosphonate.

11 ), which promotes in vivo cellular uptake of technetium 99m ((99m)Tc) or iodine 124 ((124)I), as a re

12 sm who underwent preoperative imaging with a technetium 99m ((99m)Tc) sestamibi and (99m)TcO4- protoc

13 nclusive results at ultrasonography (US) and technetium 99m ((99m)Tc) sestamibi scintigraphy.

14 on emission computed tomography (SPECT) with technetium 99m ((99m)Tc) tropane dopamine transporter (T

15 ion-perfusion SPECT with or without CT using technetium 99m ((99m)Tc)-diethylenetriaminepentaacetic a

16 maged owing to internally bound, or trapped, technetium 99m ((99m)Tc)-labeled hSSTr2-binding peptide

17 modality and biomarker is SPECT imaging with technetium 99m ((99m)Tc)-radiolabeled bone-seeking trace

18 between the lung elimination rate of inhaled technetium 99m ((99m)Tc)-sestamibi and immunohistochemic

19 iated HIV surrogate) and 18.5-MBq (500-muCi) technetium 99m ((99m)Tc)-sulfur colloid (HIV-sized 100-n

20 We performed intraoperative technetium-99m ((99m)Tc) sentinel lymph node (SN) mappin

21 was to determine the extent to which inhaled technetium-99m ((99m)Tc)-labeled carbon nanoparticles (T

22 on, for targeting human CRC xenografts using technetium-99m ((99m)Tc)-labeled TCP-1 and fluorescent c

23 r myocardial perfusion imaging of mice using technetium-99m ((99m)Tc)-sestamibi and demonstrate the f

24 imaging and to determine whether dobutamine technetium-99m ((99m)Tc)-sestamibi single-photon emissio

25 labeled with indium-111 ((111)In)-oxine and technetium-99m ((99m)Tc)-Ultratag or (99m)Tc-Ceretec.

26 e kidney MR GFR indices correlated well with technetium 99m (99mTc) diethylenetriaminepentaacetic aci

27 The targeting results of technetium 99m (99mTc)-,iodine 123 (123I)-, and iodine 1

28 In vitro binding assays of technetium 99m (99mTc)-labeled Cy7 tilmanocept were cond

29 affinity for apoptotic cells in vitro, with technetium-99m (99mTc) as a radionuclide imaging agent t

30 3) chelator has been shown to stably complex technetium-99m (99mTc) for nuclear imaging and radiorhen

31 ulty, we have studied a radiopharmaceutical, technetium-99m (99mTc) Infecton, which is based on the a

32 ne (MAG3) forms a single stable chelate with technetium-99m (99mTc) oxotechnetate.

33 ke of thallium-201 (201Tl) at rest with rest technetium-99m (99mTc) sestamibi uptake in the same pati

34 Technetium-99m (99mTc)-labeled leukocytes were quantifie

35 a novel targeted molecular imaging approach (technetium-99m [99mTc]-tilmanocept single photon emissio

36 methodology for determining the transport of technetium-99m, a gamma-emitting metastable isomer of (9

37 Technetium-99m activity was monitored with a Nal probe.

38 t peptides (P280 and P748) were labeled with technetium-99m and assessed in a canine thrombosis model

39 tent SSTR-binding peptides were labeled with technetium-99m and assessed in an in vivo study with tum

40 Tilmanocept was labeled with gallium-68, technetium-99m, and a near-infrared fluorophore.

41 nanobodies were generated, radiolabeled with technetium-99m, and screened in vitro on mouse and human

42 autologous PBMCs were isolated, labeled with technetium-99m, and visualized 3, 4.5, and 6 h post-infu

43 Technetium-99m-antimony trisulfide colloid was the radio

44 hich contain a chelator for the radionuclide technetium-99m are described.

45 hese defects were compared with risk area on technetium-99m autoradiography and infarct size on tissu

46 r short-axis slices of equal thickness using technetium-99m autoradiography and tissue staining, resp

47 mor/nontumor ratios indicate that such small technetium-99m-based molecular probes can be developed a

48 ith human recombinant annexin V labeled with technetium-99m before imaging.

49 Twenty healthy volunteers underwent technetium-99m bicisate SPECT under baseline conditions

50 Technetium-99m-bicisate/SPECT was compared prospectively

51 synthesized for incorporating the well-known technetium-99m-binding hydrazinonicotinamide ligand into

52 Overall, we show that technetium-99m bone scans done at regular intervals are

53 ulted in the formation of '3+1' mixed-ligand technetium-99m complexes [TcO(SN(R)S)(SNX(2))] in high r

54 These results suggest that small technetium-99m complexes could be useful as potential me

55 The number of lymph nodes removed, technetium-99m counts for each sentinel lymph node, pres

56 Technetium-99m-DD and 99mTc-LL-EC were excreted more rap

57 Technetium-99m-DD-EC had the highest clearance and extra

58 Technetium-99m-DD-EC has excellent imaging properties an

59 d using ex vivo SPECT following injection of technetium 99m diethylenetriamine pentaacetic acid.

60 territory caused significant acceleration of technetium-99m diethylenetriamine pentaacetic acid (Tc-9

61 ade it the radiotracer of choice compared to technetium-99m diethylenetriamine pentaacetic acid (Tc-9

62 Simultaneous renal scans (technetium-99m diethylenetriamine pentaacetic acid) of t

63 9 ((129)Xe) MRI (hereafter, (129)Xe MRI) and technetium 99m-diethylenetriaminepentaacetic acid aeroso

64 elates with hyperpolarized xenon 129 MRI and technetium 99m-diethylenetriaminepentaacetic acid aeroso

65 7-labeled egg and intravenously administered technetium 99m diisopropyl-imino-diacetic acid were imag

66 ratively, and 1 year later, ultrasonography, technetium 99m-dimercaptosuccinic acid (DMSA) scintigrap

67 aphy scans for MIBG-nonavid disease, replace technetium-99m diphosphonate bone scintigraphy for osteo

68 Technetium-99m-disofenin is a suitable label for solidph

69 Technetium-99m-disofenin labeling resulted in in vitro p

70 Technetium-99m-DTPA aerosol clearance measurements can b

71 Technetium-99m-DTPA distributed uniformly without signif

72 Technetium-99m-ECD shows greater contrast than 99mTc-HMP

73 Technetium-99m-ECD SPECT and 18F-FDG PET showed regional

74 xenon-133 in 261 patients and with injected technetium-99m hexamethyl-propyleneamine oxime (HMPAO) i

75 structured psychiatric interview and resting technetium 99m-hexamethyl-propyleneamine oxime single ph

76 ctice CD16 CliniMACS isolation, labeled with technetium 99m-hexamethylpropyleneamine oxime, and then

77 uthors' goal was to evaluate the accuracy of Technetium 99m-HMPAO-labeled leukocyte imaging for scree

78 Technetium-99m-HMPAO and 99mTc-MIBI brain SPECT, MRI, CT

79 Technetium-99m-HMPAO brain SPECT can detect cerebral per

80 Technetium-99m-HMPAO distribution was evaluated in 14 pa

81 Technetium-99m-HMPAO interictal SPECT was performed on t

82 Technetium-99m-HMPAO ROI data also were expressed in uni

83 Technetium-99m-HMPAO was injected intravenously while th

84 Technetium-99m-HSA demonstrated faster washout rates fro

85 Technetium-99m-HSA was supplied commercially.

86 In vivo localization of technetium 99m hydrazinonicotinamide-annexin V was teste

87 Technetium 99m hydroxymethane diphosphonate SPECT/CT bon

88 Radiolabeling with technetium-99m in aqueous media was efficient and gave r

89 inoembryonic antigen (CEA) Fab' labeled with technetium-99m, in the presurgical evaluation of patient

90 and contain a chelator for the radionuclide technetium-99m is described.

91 Technetium-99m is the workhorse of diagnostic nuclear me

92 Technetium-99m-L,L-ethylenedicysteine (99mTc-LL-EC) is a

93 ction of apoptosis, such as that achieved by technetium-99m labeled Annexin-A5 scintigraphy.

94 he 41 mice, 6, 6, and 5 received intravenous technetium-99m labeled CRIP for micro-single-photon emis

95 maging of metastatic melanoma has shown that technetium-99m-labeled AADT-(CH2)2-NEt2 (99mTc-1) has th

96 the deposition and clearance of an ultrafine technetium-99m-labeled aerosol in 10 patients with chron

97 Technetium-99m-labeled annexin-V, an endogenous protein

98 tivity in experimental atherosclerosis using technetium-99m-labeled broad matrix metalloproteinase in

99 ocyte accumulation was assessed by uptake of technetium-99m-labeled chemotactic peptide (fMLFK) and c

100 the results of experiments with intravenous technetium-99m-labeled deimmunized antifibrin Fab' fragm

101 Serial technetium-99m-labeled dimercaptosuccinic acid ((99m)Tc-

102 urinary tract infection; renal scanning with technetium-99m-labeled dimercaptosuccinic acid has also

103 hrombi (DVTs) were formed in five dogs, then technetium-99m-labeled Fab' ( approximately 400 mg, appr

104 Technetium-99m-labeled matrix metalloproteinase inhibito

105 computed tomographic imaging, using RP805, a technetium-99m-labeled MMP-specific tracer, followed by

106 hma (FEV1, 76.8 +/- 11.4% predicted) inhaled technetium-99m-labeled monodisperse albuterol aerosols (

107 Technetium-99m-labeled nitroimidazole was administered t

108 Technetium-99m-labeled peptides and monoclonal antibody

109 Technetium-99m-labeled polydiethylenetriamine pentaaceti

110 It was used to synthesize a technetium-99m-labeled salmon calcitonin with the hynic-

111 iagnostic efficacy of flurpiridaz PET versus technetium-99m-labeled single photon emission computed t

112 stress and time control were estimated using technetium-99m labelled autologous red blood cells and g

113 were determined by gamma camera imaging with technetium-99m labelled erythrocytes.

114 acement and had ECG-gated CT angiography and Technetium-99m-labelled 3,3-diphosphono-1,2-propanodicar

115 Technetium-99m-liposome images showed prominent blood-po

116 Technetium-99m-liposomes, independent of surface modific

117 er tumor radiation-absorbed dose computed at technetium 99m macroaggregated human albumin SPECT/CT wa

118 Work-up angiography and technetium 99m-macroaggregated albumin injection were pe

119 Technetium 99m-macroaggregated albumin was injected unde

120 Technetium-99m-MDP uptake in primary breast carcinoma ha

121 A technetium-99m-mebrofenin scan showed a photopenic area

122 The better quality of images obtained with technetium-99m mercaptoacetyltriglycine (Tc-99m MAG3) ha

123 s and enhanced renal plasma flow measured by Technetium-99m mercaptoacetyltriglycine scintigraphy.

124 iography (Fig 1A) and bone scintigraphy with technetium 99m methylene diphosphonate (Fig 1B).

125 Technetium-99m-MIBI images, rather than 99mTc-HMPAO brai

126 Technetium-99m-N-NOET bound to RBCs was subsequently ext

127 Technetium-99m-N-NOET has high binding affinity to blood

128 Technetium-99m-N-NOET is a new 99mTc-labeled, neutral ca

129 Technetium-99m-N-NOET myocardial uptake (%ID) was signif

130 Technetium-99m-P483H also outperformed all controls, inc

131 Technetium-99m-P483H associated predominantly with WBCs

132 Technetium-99m-P483H associates predominantly with WBCs

133 Technetium-99m-P483H outperformed 111In-WBCs, 111In-DTPA

134 Technetium-99m-P483H was evaluated for its ability to se

135 Technetium-99m-P483H was incubated with citrated whole h

136 Technetium-99m-P587 and 99mTc-P829 of high-specific acti

137 Technetium-99m-P748 was prepared by either a ligand exch

138 Technetium-99m-P748 was readily prepared at room tempera

139 The aim of the work is to analyze the technetium-99m patents since 2000 to photograph its inno

140 After intravenous application of 75 MBq of technetium 99m pertechnetate, freehand three-dimensional

141 vary gland excretory function measured using technetium-99m pertechnetate scintigraphy, patient-repor

142 Within 2 hours of US, technetium-99m pertechnetate was intravenously administe

143 gen (CEA) Fab antibody fragment labeled with technetium-99m-pertechnetate (99mTc), was injected intra

144 In single-center studies, technetium 99m pyrophosphate (Tc 99m PYP) cardiac imagin

145 Cardiac assessments, including technetium-99m pyrophosphate scintigraphy and biopsy, ru

146 Cardiac scintigraphy with technetium-99m-pyrophosphate (99mTc-PyP) labeled bone-se

147 patients with suspected ATTR-CM referred for technetium-99m-pyrophosphate scintigraphy.

148 referred to 3 major amyloidosis centers for technetium-99m-pyrophosphate to detect ATTR-CM were anal

149 Technetium-99m-Q57, 99mTc-Q58 and 99mTc-Q63 are avid tra

150 m, collected via apheresis, and labeled with technetium-99m radioisotope for single-photon emission c

151 mine transporter levels were measured with a technetium-99m radiolabeled analog of cocaine, TRODAT-1,

152 gh specificity of SPECT/CT examination using technetium-99m radiolabeled red blood cells (Tc-99m-RBC)

153 The introduction of new technetium-99m radiopharmaceuticals into clinical routin

154 analysis have shown that SPECT imaging using technetium-99m radiopharmaceuticals is still robust.

155 Technetium-99m-red blood cell (RBC) scintigraphy was und

156 m-enhanced inversion-recovery MR imaging and technetium-99m renal cortical scintigraphy.

157 to 58) for a dual-isotope (thallium-201 plus technetium-99m) scan.

158 inologist (S.J.M.), who decided to perform a technetium 99m sestamibi ((99m)Tc MIBI) parathyroid scan

159 y and gamma imaging after a 740-mBq (20-mCi) technetium 99m sestamibi injection.

160 cy compared with that of ultrasonography and technetium 99m sestamibi scanning may be sufficient to a

161 A drawn dose of 8 mCi (296 MBq) of technetium 99m sestamibi was administered to all patient

162 After injection of 740 MBq technetium 99m sestamibi, craniocaudal and mediolateral

163 r injection with 25-30 mCi (925-1110 MBq) of technetium 99m sestamibi, patients were imaged with a hi

164 s on the functional uptake of a radiotracer, technetium 99m sestamibi, to reveal cancers that are occ

165 Parathyroid imaging using technetium-99m sestamibi (MIBI) has evolved and can loca

166 rfusion imaging with thallium-201 (n=173) or technetium-99m sestamibi (n=72) and either dipyridamole

167 The technique involved injecting 20 mCi technetium-99m sestamibi 2 hours before surgery and perf

168 s suggest that early perfusion imaging using technetium-99m sestamibi enables reliable risk stratific

169 t ventricular (LV) function from post-stress technetium-99m sestamibi gated SPECT performed >15 min a

170 ts who underwent rest thallium-201/adenosine technetium-99m sestamibi MPS, 254 (4.1%) were lost to fo

171 wall thickening from three-dimensional gated technetium-99m sestamibi myocardial perfusion single-pho

172 assess the diagnostic efficacy of adenosine technetium-99m sestamibi myocardial perfusion single-pho

173 n fractions can be obtained from gated SPECT technetium-99m sestamibi perfusion images using the imag

174 Same-day rest and dipyridamole technetium-99m sestamibi single photon emission computed

175 cardiac magnetic resonance (CMR) imaging or technetium-99m sestamibi single-photon emission computed

176 cise variables of rest thallium-201/exercise technetium-99m sestamibi single-photon emission computed

177 either cardiac magnetic resonance imaging or technetium-99m sestamibi single-photon emission computed

178 easurement of infarct size by serum markers, technetium-99m sestamibi single-photon emission computed

179 ribution thallium-201 imaging and dobutamine technetium-99m sestamibi SPECT imaging.

180 Infarct size, measured by CMR or technetium-99m sestamibi SPECT within 1 month after prim

181 the ability of early perfusion imaging using technetium-99m sestamibi to predict adverse cardiac outc

182 was measured in a subset of 243 patients by technetium-99m sestamibi tomography.

183 Technetium-99m sestamibi uptake after injection at rest

184 Technetium-99m sestamibi uptake was not significantly di

185 Technetium-99m sestamibi was injected 3 min after the co

186 erfusion images using either thallium-201 or technetium-99m sestamibi, and no previous coronary revas

187 was performed on the stress distribution of technetium-99m sestamibi, using eight frames per cardiac

188 est pain underwent MP imaging with SPECT and technetium-99m sestamibi.

189 gnostic performance of parathyroid 4D CT and technetium 99m-sestamibi (hereafter, referred to as sest

190 ommended dose of 740-1100 MBq (20-30 mCi) of technetium 99m-sestamibi is estimated to involve an LAR

191 Technetium-99m-sestamibi activity in the ischemic zone (

192 Technetium-99m-sestamibi appears to indicate the extent

193 Technetium-99m-sestamibi has recently been validated as

194 size with cardiac marker release patterns or technetium-99m-sestamibi single-photon emission computed

195 Technetium-99m-sestamibi was injected intravenously at p

196 and after 300 mL of Ensure was measured with technetium-99m single-photon emission computed tomograph

197 review of studies where either Rb-82 PET or technetium-99m SPECT with both attenuation correction an

198 zation of sentinel lymph nodes with filtered technetium 99m sulfur colloid.

199 technique involved the injection of 4 ml of technetium-99m sulfur colloid (1 mCi [37 MBq]) into the

200 A modified preparation of technetium-99m sulfur colloid with smaller particles tha

201 Technetium-99m-sulfur colloid also forms particles and t

202 SLN mapping requires injection of technetium-99m-sulfur colloid-an effective but sometimes

203 ed tomography (SPECT) after the injection of technetium-99m (Tc-99m) sestamibi at rest.

204 LV) function and infarct size as assessed by technetium-99m (Tc-99m) sestamibi perfusion tomographic

205 e addition of electrocardiographically gated technetium-99m (Tc-99m) sestamibi single-photon emission

206 Technetium-99m (Tc-99m) sestamibi was injected before re

207 rest left ventricular volumes during stress technetium-99m (Tc-99m) sestamibi/rest thallium-201 dual

208 We compared dipyridamole technetium-99m (Tc-99m) tetrofosmin and thallium-201 (Tl

209 clinical use and cost-analysis of acute rest technetium-99m (Tc-99m) tetrofosmin single-photon emissi

210 photon emission computed tomographic (SPECT) technetium-99m (Tc-99m) tracer imaging in patients with

211 r repairs that led to a critical shortage of technetium-99m (Tc-99m).

212 Our objective is to prove that injection of technetium-99m (Tc99) sulfur colloid in a subareolar man

213 Technetium-99m-teboroxime clearance is markedly accelera

214 exercise (44%) or pharmacologic stress (56%) technetium-99m tetrofosmin SPECT.

215 Technetium-99m-tetrofosmin uptake was compared to that o

216 ients with suspected CAD who underwent CCTA, technetium 99m/tetrofosmin-labeled SPECT, and [15O]H2O P

217 o labeling of leukocytes with indium-111 and technetium-99m that subsequently migrate to foci of infe

218 Technetium-99m, the most commonly used radionuclide in n

219 We report a phenformin complex with the technetium-99m tricarbonyl [(99m)Tc(CO)(3)], termed (99m

220 Technetium-99m TRODAT-1 is an analog of cocaine that sel

221 od cells (RBCs), labeled with chromium-51 or technetium-99m, were separately coated to equal levels w

222 Complexation of technetium-99m with a mixture of N-R(3-azapentane-1,5-di